Isogenica

Isogenica is hiring to add strength and depth to our team and to increase our commitment to partnerships with biopharma

 

Isogenica is increasing our commitment to partnerships with biopharma.  We’ve seen important shifts in the way pharma and biotech want to engage with Isogenica, and we’re embracing the opportunity for change by adding strength and depth to our team so that we can continue to work as trusted partners with a wider group of pioneering biopharma companies. We’re recruiting to fill several vacancies including a newly created role of Director of Antibody Discovery and a Senior Scientist team lead role.

Posts will be advertised on our website now and over the coming weeks, so take a look and please get in touch if you, or someone you know, are interested in a role at Isogenica.

 

 Visit our jobs page

 

Isogenica is at the forefront of synthetic biology, pursuing a mission to provide the fastest, most efficient engine for therapeutic antibody discovery. We are passionate about using our platform technologies to improve and accelerate drug discovery and development. Working with pharmaceutical industry partners, we are driven by the ultimate goal of helping patients though more affordable medicines and faster access to potentially life changing treatments.

 

 

Events
News

9
Jul

Discovery on Target 2019

Boston, MA, USA | 16th to 19th September 2019
 
Isogenica is pleased to be speaking at Discovery on Target 2019. We look forward to meeting you there.

Read More
14
Jun

Festival of Biologics: European Antibody Congress

Basel, Switzerland 14th - 17th October 2018
 
Isogenica is pleased to be attending and presenting at this event.

Read More

10
Jul

Isogenica expands team

 

Isogenica is hiring to add strength and depth to our team and to increase our commitment to partnerships with biopharma.

 

Read More
7
Jan

Isogenica expands collaboration with Aro Biotherapeutics

Cambridge, UK, 7th January 2019

 Expansion of the collaboration and license agreement signed with Aro Biotherapeutics 

Read More

Isogenica is Hiring